Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dobutamine Hydrochloride for Injection

Approval Number

国药准字H20040383

Company湖北美林药业有限公司

Registration Date

April 30, 2021

Previous Approval Numbers

国药准字H20040383

Drug Information

Generic Name

注射用盐酸多巴酚丁胺

Trade Name

安畅

Dosage Form

注射剂(注射用无菌粉末)

Strength

0.25g(以多巴酚丁胺C18H23NO3计)

Drug Type

化学药品

Registration Date

April 30, 2021

Company Information

Applicant Company

Company Name湖北美林药业有限公司

Company Address

湖北省孝感市云梦县经济开发区和平路8号

Manufacturing Company

Company Name正安医药（四川）有限公司

Company Address

四川省乐山市市中区绵竹工业开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy